Effects of low doses of lactitol on faecal microflora, pH, short chain fatty acids and gastrointestinal symptomology
- 356 Downloads
Lactitol (4-β-d-galactopyranosyl-d-glucitol) is a sugar alcohol used as a sweetener. Previous studies have shown that it has a beneficial effect on intestinal microflora.
Aims of the study
To determine whether low doses of lactitol had beneficial effects without eliciting adverse gastrointestinal symptoms.
Faecal bacterial populations (total anaerobes, total aerobes, enterobacteria, bifidobacteria and lactobacilli), faecal pH and faecal short chain fatty acids (SCFA) were studied in a randomized longitudinal study of 75 non-adapted healthy adults before and after consumption of low doses of lactitol. Subjects consumed 25 g tablets of milk chocolate containing 10 g sweetener as sucrose:lactitol in ratios of 10:0, 5:5 or 0:10 daily for 7 d.
No significant changes in faecal bacterial counts occurred in the 10:0 or 5:5 sucrose:lactitol groups. There were no significant changes in faecal anaerobes, aerobes, Enterobacteriaceae or lactobacilli during the study period in subjects consuming 0:10 sucrose:lactitol but there was a significant increase (P = 0.017) in bifidobacteria. There were no significant changes in faecal pH and SCFA for the 10:0 or 5:5 sucrose:lactitol groups but a significant decrease (P = 0.02) in faecal pH and significant increases (P = 0.001) in concentrations of propionic and butyric acids were observed in the 0:10 sucrose:lactitol group. There were few adverse symptoms of gastrointestinal intolerance to the daily consumption of 10 g lactitol.
The results show that low doses of lactitol can beneficially affect the faecal flora without eliciting gross symptoms of intolerance and that lactitol can be classified as a prebiotic.
Keywordsbifidobacterium faecal microflora lactitol short chain fatty acids gastrointestinal symptomology
This study was supported by Purac Biochem, Holland.
- 2.Anon (1988) Association of the British pharmaceutical industry (ABPI). Patient information and consent for clinical trials. ABPI: LondonGoogle Scholar
- 4.Ballongue J, Schumann C, Quignon P (1997) Effects of lactulose and lactitol on colonic microflora and enzymic activities. Scand J Gastroenterol 222:S41–S44Google Scholar
- 5.Beaugerie L, Flourié B, Pellier P, Achour L, Franchisseur C, Rambaud JC (1991) Tolérance clinique, absorption intestinale et valeur énergétique de quatre polyols pris à jeun (clinical tolerance, intestinal absorption, and energy value of four sugar alcohols). Gastroenterol Clin Biol 15:929–932Google Scholar
- 7.Cummings JH, Gibson GR, Macfarlane GT (1989) Quantitative estimates of fermentation in the hindgut of man. Acta Vet Scand 86:S76–S82Google Scholar
- 8.Cummings JH, Macfarlane GT (1991) The control and consequences of bacterial fermentation in the human colon. J Appl Bacteriol 70:443–459Google Scholar
- 9.Cummings JH, Macfarlane GT, Englyst HN (2001) Prebiotic digestion and fermentation. Am J Clin Nutr 72:S415–S420Google Scholar
- 10.Gibson GR, Fuller R (1998) The role of probiotics and prebiotics in the functional food concept. In: Sadler MJ, Saltmarsh M (eds) Functional foods: the consumer, the products and the evidence. The Royal Society of Chemistry, London, pp 3–14Google Scholar
- 11.Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota: introducing the concepts of prebiotics. J Nutr 125:1401–1412Google Scholar
- 12.Goovaerts L, Ravelli GP (1993) Lactitol monohydrate for the treatment of chronic constipation-a multicentre study of the efficacy and tolerability of an individually adjusted daily dose. Acta Therapeut 19:61–71Google Scholar
- 13.Grimble GK, Patil DH, Silk DB (1988) Assimilation of lactitol, an ‘unabsorbed’ disaccharide in the normal human colon. Gut 29:1666–1671Google Scholar
- 17.Koutsou GA, Storey DM, Lee A, Zumbe A, Flourie B, LeBot Y, Olivier P (1996) Dose related gastrointestinal response to the ingestion of either isomalt, lactitol or maltitol in milk chocolate. Eur J Clin Nutr 50:17–21Google Scholar
- 18.Lanthier PL, Morgan MY (1985) Lactitol in the treatment of chronic hepatic encephalopathy; an open comparison with lactulose. Gut 26:415–420Google Scholar
- 21.Macfarlane GT, Cummings JH (1991) The colonic flora, fermentation and large bowel digestive function. In: Philips SF, Pemberton JH, Shorter RG (eds) The large intestine: physiology, pathophysiology and disease. Raven Press Ltd, New York, pp 51–92Google Scholar
- 22.Macfarlane GT, Cummings JH (1999) Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ 318:999–1003Google Scholar
- 23.Macfarlane GT, Gibson GR (1995) Microbiological aspects of the production of short-chain fatty acids in the large bowel. In: Cummings JH, Rombeau JL, Sakata T (eds), Physiological and clinical aspects of short-chain fatty acids. Cambridge University Press, Cambridge pp 87–105Google Scholar
- 25.Marteau P, Flourie B (2001) Tolerance to low-digestible carbohydrates: symptomatology and methods. Br J Nutr 85:S17–S21Google Scholar
- 26.Marteau P, Pochart P, Flourie B, Pellier P, Santos L, Desjeux JF, Rambaud JC (1990) Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora of humans. Am J Clin Nutr 52:685–888Google Scholar
- 27.Minekus M, Smeets-Peeters M, Bernalier A, Marol-Bonnin S, Havenaar R, Marteau P, Alric M, Fonty G, Huis in’t Veld JHJ (1999) A computer controlled system to stimulate conditions of the large intestine with peristaltic mixing, water absorption and absorption of fermentation products. Appl Microbiol Biotechnol 53:108–114CrossRefGoogle Scholar
- 31.Rambaud JC, Flourie B (1994) Mechanisms of carbohydrate induced diarrhoea. In: Binder HJ, Cummings JH, Soergel K (eds) Short chain fatty acids. Kluwer Academic Press, pp 232–239Google Scholar
- 32.Ravelli GP, Whyte A, Spencer R, Hotten P, Harbron C, Keenan R (1995) Effect of lactitol intake upon stool parameters and the faecal bacterial flora in chronically constipated women. Acta Ther 21:243–255Google Scholar
- 33.Roberfroid MB (2001) Prebiotics: preferential substrates for specific germs? Am J Clin Nutr 73:S406–S409Google Scholar
- 35.Scevola D, Bottari A, Franchini A, Guanziroli A, Faggi A, Monzillo V, Pervesi L, Oberto L (1993) The role of lactitol in the regulation of the intestinal microflora in liver disease. Giorn Ital Malatt Infett Parassit 45:906–918Google Scholar
- 38.Suau A, Bonnet R, Sutren M, Godon J-J, Gibson GR, Collins MD, Dore J (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65:4799–4807Google Scholar
- 39.Tarao K, Tamai S, Ito Y, Okawa S, Hayashi M (1995) Effects of lactitol on faecal bacterial flora in patients with liver cirrhosis and hepatic encephalopathy. Japan J Gastroenterol 92:1037–1050Google Scholar
- 40.Vanderdonckt J, Coulon J, Denys W, Ravelli GP (1990) Study of the laxative effect of lactitol (Importal®) in the elderly institutionalized, but not bedridden, population suffering from chronic constipation. J Clin Exp Gerontol 12:171–189Google Scholar
- 41.Wang X, Gibson GR (1993) Effects of the in vitro fermentation of oligofructose and insulin by bacteria growing in the human large intestine. J Appl Bacteriol 75:373–380Google Scholar
- 42.Wilson KH, Blitchington RB (1996) Human colonic biota studied by ribosomal DNA sequence analysis. Appl Environ Microbiol 62:2273–2278Google Scholar
- 43.Wollowski I, Rechkemmer G, Pool-Zobel BL (2001) Protective role of probiotics and prebiotics in colon cancer. Am J Clin Nutr 73:451–455Google Scholar
- 44.Yanahira S, Morita M, Aoe S, Suguri T, Nakajima I, Deya E (1995) Effects of lactitol-oligosaccharide on the intestinal microflora in rats. J Nutr Sci Vitaminol (Tokyo) 41:83–94Google Scholar